BioMarin Pharmaceuticals BMRN Rest of world — Revenue
Discontinued — last reported Q3 '21
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed October 29, 2021, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's rest of world — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's rest of world — revenue?
- BioMarin Pharmaceuticals (BMRN) reported rest of world — revenue of $58.05M in Q3 2021.
- What does rest of world — revenue mean?
- The total revenue earned from sales in all international geographic regions excluding the company's primary home market.
- How do you interpret rest of world — revenue?
- An increase indicates successful international market expansion and growing demand for the company's therapies, whereas a decrease may signal competitive pressure or regulatory hurdles in those regions.
- How does rest of world — revenue compare across companies?
- Most global pharmaceutical companies report revenue by geographic segment, making this directly comparable to 'International' or 'Rest of World' revenue lines in peer financial statements.